Citation Impact
Citing Papers
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
2010
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Fosfomycin
2016
Infective Endocarditis
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies
2009
Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens
2008
Taking inventory: antibacterial agents currently at or beyond Phase 1
2004
Tigecycline: A Critical Analysis
2006
High prevalence of ESBL-producingEscherichia coliandKlebsiella pneumoniaein community-onset bloodstream infections in China
2016
Antibacterial Dosing in Intensive Care
2006
In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation
2011
Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime
2013
Tigecycline: First of a New Class of Antimicrobial Agents
2006
Recognition of specific sialoglycan structures by oral streptococci impacts the severity of endocardial infection
2019
Behavior Change Strategies to Influence Antimicrobial Prescribing in Acute Care: A Systematic Review
2011
Randomized, Double-Blind Comparison of Once-Weekly Dalbavancin versus Twice-Daily Linezolid Therapy for the Treatment of Complicated Skin and Skin Structure Infections
2005
Management of infective endocarditis: challenges and perspectives
2012
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Management of multidrug-resistant enterococcal infections
2010
Emergence and management of drug-resistant enterococcal infections
2008
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Unique Features of Infective Endocarditis in Childhood
2002
Imaging investigations in infective endocarditis: Current approach and perspectives
2012
Central Nervous System Aspergillosis
2012
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy
2006
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
2015
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Update on Infective Endocarditis
2006
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
2016 Standout
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin
2010
The role of antibiotics and antibiotic resistance in nature
2009
Pharmacokinetic issues for antibiotics in the critically ill patient
2009
Infection in Solid-Organ Transplant Recipients
2007 Standout
Effect of Penicillin Resistance ofStreptococcus pneumoniaeon the Presentation, Prognosis, and Treatment of Pneumococcal Endocarditis in Adults
2002
The accuracy of Gram stain of respiratory specimens in excluding Staphylococcus aureus in ventilator-associated pneumonia
2014
In vitro activity of tigecycline against Bacteroides species
2005
Tigecycline: A New Glycylcycline for Treatment of Serious Infections
2005
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Synthesis of Oxacycles Employing the Oxa‐Pictet–Spengler Reaction: Recent Developments and New Prospects
2011
High field dielectric properties of anisotropic polymer-ceramic composites
2008
Linezolid Therapy of Vancomycin-Resistant Enterococcus faecium Experimental Endocarditis
2001
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
The Carriage Population of Staphylococcus aureus from Mali Is Composed of a Combination of Pandemic Clones and the Divergent Panton-Valentine Leukocidin-Positive Genotype ST152
2008
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
AspergillusInfections in Transplant Recipients
2005
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Flexible Nanodielectric Materials with High Permittivity for Power Energy Storage
2013 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Infective Endocarditis in Childhood: 2015 Update
2015
Effect of Medium Age and Supplementation with the Biocatalytic Oxygen-Reducing Reagent Oxyrase on In Vitro Activities of Tigecycline against Recent Clinical Isolates
2005
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections
2013
Origins and Evolution of Antibiotic Resistance
2010 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Diversity of Staphylococcal Cassette Chromosome mec Structures in Methicillin-Resistant Staphylococcus epidermidis and Staphylococcus haemolyticus Strains among Outpatients from Four Countries
2008
Nitrated Confined Imidodiphosphates Enable a Catalytic Asymmetric Oxa-Pictet–Spengler Reaction
2016 StandoutNobel
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Streptococcal Siglec-like adhesins recognize different subsets of human plasma glycoproteins: implications for infective endocarditis
2018
New antimicrobial agents for the treatment of Gram-positive bacterial infections
2008
Works of A. Lefort being referenced
Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment
2008
Antibiotic use: knowledge and perceptions in two university hospitals
2011
Streptococcus pneumoniae Endocarditis in Adults: A Multicenter Study in France in the Era of Penicillin Resistance (1991-1998)
2000
Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase
2013
Two Cases of Cerebral Aspergillosis Successfully Treated with Voriconazole
2003
Fungal endocarditis: current challenges
2014
Comparison Between Adult Endocarditis Due to β-Hemolytic Streptococci (Serogroups A, B, C, and G) and Streptococcus milleri<subtitle>A Multicenter Study in France</subtitle>
2002
Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features
2010
Diagnosis, management and outcome of Candida endocarditis
2012
Two-Step Acquisition of Resistance to the Teicoplanin-Gentamicin Combination by VanB-Type Enterococcus faecalis In Vitro and in Experimental Endocarditis
1999
Technetium 99m–Labeled Annexin V Scintigraphy of Platelet Activation in Vegetations of Experimental Endocarditis
2008
The In Vitro Contribution of Autolysins to Bacterial Killing Elicited by Amoxicillin Increases with Inoculum Size in Enterococcus faecalis
2010
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Relaxation phenomenon in composite materials
1998
Accuracy and Potential Usefulness of Triplex Real-Time PCR for Improving Antibiotic Treatment of Patients with Blood Cultures Showing Clustered Gram-Positive Cocci on Direct Smears
2008
Contribution of the Autolysin AtlA to the Bactericidal Activity of Amoxicillin against Enterococcus faecalis JH2-2
2009
Activity and Diffusion of Tigecycline (GAR-936) in Experimental Enterococcal Endocarditis
2002
Activity of LY333328 Combined with Gentamicin In Vitro and in Rabbit Experimental Endocarditis Due to Vancomycin-Susceptible or -Resistant Enterococcus faecalis
2000
Activities of Dalbavancin In Vitro and in a Rabbit Model of Experimental Endocarditis Due to Staphylococcus aureus with or without Reduced Susceptibility to Vancomycin and Teicoplanin
2004
Influence of Reduced Susceptibility to Glycopeptides on Activities of Vancomycin and Teicoplanin against Staphylococcus aureus in Experimental Endocarditis
2003
Activity and Diffusion of LY333328 in Experimental Endocarditis Due to Vancomycin-Resistant Enterococcus faecalis
1999